Publications (12) Publications auxquelles un chercheur a participé

2011

  1. BiovaxID®: A customized idiotype vaccine for the treatment of B-cell lymphoma

    Expert Review of Vaccines, Vol. 10, Núm. 12, pp. 1661-1669

  2. Carcinoma-derived Interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation

    PLoS ONE, Vol. 6, Núm. 3

  3. Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes

    PLoS ONE, Vol. 6, Núm. 12

  4. Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens

    Leukemia Research, Vol. 35, Núm. 10, pp. 1412-1415

  5. Direct effects of type I interferons on cells of the immune system

    Clinical Cancer Research, Vol. 17, Núm. 9, pp. 2619-2627

  6. IV Latin American consensus on the treatment of lymphedema

    Journal Phlebology and Lymphology, Vol. 4, Núm. 1, pp. 13-16

  7. Idiotype vaccines for lymphoma therapy

    Expert Review of Vaccines, Vol. 10, Núm. 6, pp. 801-809

  8. Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy

    International Journal of Cancer, Vol. 128, Núm. 1, pp. 105-118

  9. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients

    Journal of Immunology, Vol. 187, Núm. 11, pp. 6130-6142

  10. Simb16: Modeling induced immune system response against B16-melanoma

    PLoS ONE, Vol. 6, Núm. 10

  11. Stem cell transplant and idiotypic vaccination for B-cell malignancies

    Current Topics in Medicinal Chemistry, Vol. 11, Núm. 13, pp. 1653-1660

  12. Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo

    International Journal of Cancer, Vol. 129, Núm. 2, pp. 374-386